306
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Drug–carrier interaction analysis in the cell penetrating peptide-modified liposomes for doxorubicin loading

, , , , &
Pages 745-754 | Received 07 Feb 2015, Accepted 06 Jul 2015, Published online: 21 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chang Liu, Xiao-Na Liu, Gui-Ling Wang, Yu Hei, Shuai Meng, Ling-Fei Yang, Lan Yuan & Ying Xie. (2017) A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells. International Journal of Nanomedicine 12, pages 2407-2425.
Read now
Yuan Ding, Wei Cui, Dan Sun, Gui-Ling Wang, Yu Hei, Shuai Meng, Jian-Hua Chen, Ying Xie & Zhi-Qiang Wang. (2017) In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors. Drug Design, Development and Therapy 11, pages 3105-3117.
Read now

Articles from other publishers (2)

Maciej Gagat, Wioletta Zielińska & Alina Grzanka. (2017) Cell-penetrating peptides and their utility in genome function modifications (Review). International Journal of Molecular Medicine.
Crossref
Tymofii Yu. Nikolaienko. (2017) Interaction of anticancer drug doxorubicin with sodium oleate bilayer: Insights from molecular dynamics simulations. Journal of Molecular Liquids 235, pages 31-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.